Literature DB >> 8997284

Glycogen depletion contributes to ischemic preconditioning in the rat heart in vivo.

P H McNulty1, A Darling, J M Whiting.   

Abstract

Ischemic preconditioning depletes the myocardium of glycogen, thus blunting lactic acidosis during subsequent episodes of ischemia. Preconditioning also protects against reperfusion arrhythmias and infarction. To test whether glycogen depletion is necessary for this ischemic tolerance, we preconditioned two groups of intact rats with a series of 3-min coronary artery occlusions. In one group, preconditioning lowered the glycogen concentration of the ischemic region by approximately 50% (24.9 +/- 2.5 to 12.5 +/- 1.8 mumol/g; P < 0.01). In the other, the heart was first loaded with glycogen via glucose-insulin infusion so that preconditioning merely reduced its glycogen concentration back to normal physiological levels. Compared with nonpreconditioned control rats, preconditioned rats with both normal and subnormal glycogen concentrations were protected from reperfusion arrhythmias after a 6-min coronary occlusion (incidence: control rats, 100%; normal glycogen rats, 11%; reduced glycogen rats, 11%). In contrast, only rats with subnormal glycogen concentration after preconditioning exhibited reduced lactate formation and infarct size after a 45-min coronary occlusion [infarct size (percentage of risk area): control rats, 53 +/- 10%; normal glycogen rats, 50 +/- 16%, P = not significant; subnormal glycogen rats, 18 +/- 10%, P < 0.01]. Thus, in the intact rat, myocardial glycogen depletion appears to be necessary for the infarct-limiting, but not for the antiarrhythmic, effects of ischemic preconditioning.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997284     DOI: 10.1152/ajpheart.1996.271.6.H2283

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits.

Authors:  S Minatoguchi; M Arai; Y Uno; T Kariya; Y Nishida; K Hashimoto; M Kawasaki; G Takemura; T Fujiwara; H Fujiwara
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Mechanisms whereby glucose deprivation triggers metabolic preconditioning in the isolated rat heart.

Authors:  M M Awan; S Makaula; S Forresti; M N Sack; L H Opie
Journal:  Mol Cell Biochem       Date:  2000-08       Impact factor: 3.396

3.  Activation of cardiac muscarinic receptor and ischemic preconditioning effects in in situ rat heart.

Authors:  F Yamaguchi; Y Nasa; K Yabe; S Ohba; Y Hashizume; H Ohaku; K Furuhama; S Takeo
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

Review 4.  The role of succinate and ROS in reperfusion injury - A critical appraisal.

Authors:  Tatyana N Andrienko; Philippe Pasdois; Gonçalo C Pereira; Matthew J Ovens; Andrew P Halestrap
Journal:  J Mol Cell Cardiol       Date:  2017-07-05       Impact factor: 5.000

Review 5.  Glucose Metabolism in Cardiac Hypertrophy and Heart Failure.

Authors:  Diem H Tran; Zhao V Wang
Journal:  J Am Heart Assoc       Date:  2019-06-12       Impact factor: 5.501

Review 6.  The role of hexokinase in cardioprotection - mechanism and potential for translation.

Authors:  Andrew P Halestrap; Gonçalo C Pereira; Philippe Pasdois
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

7.  Cyclophilin D ablation is associated with increased end-ischemic mitochondrial hexokinase activity.

Authors:  Rianne Nederlof; Mark A M van den Elshout; Anneke Koeman; Laween Uthman; Iris Koning; Otto Eerbeek; Nina C Weber; Markus W Hollmann; Coert J Zuurbier
Journal:  Sci Rep       Date:  2017-10-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.